Here, we reported that upregulation and overexpression of ERK5 in several tumor types are associated with advanced stage, metastases, and worse overall survival, highlighting the clinical significance and the prognostic value of ERK5 deregulation in human cancer. This evidence concerns the gene MAPK7 and neoplasm.